Cyclerion Therapeutics

+$0.13 (+4.44%) As of 5:21 PM UTC today

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell CYCN and other ETFs, options, and stocks.

About CYCN

Cyclerion Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovery, development, and commercialization of treatments for serious and orphan diseases, through the use of soluble guanylate cyclase (sGC) pharmacology. Its product pipeline includes several sGC stimulators, a small molecules that act synergistically with nitric oxide on sGC to boost production of cyclic guanosine monophosphate (cGMP).

CEO
Peter M. Hecht
Employees
34
Headquarters
Cambridge, Massachusetts
Founded
2018

CYCN Key Statistics

Market Cap
146.16M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
1.24M
High Today
$3.11
Low Today
$2.88
Open Price
$2.89
Volume
368.87K
52 Week High
$8.96
52 Week Low
$2.08

CYCN Earnings

-$0.95
-$0.63
-$0.32
$0.00
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Estimated
— per share
Actual
-$0.43 per share
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure